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We developed a modified complex of pDNA and poly-L-lysine (PLL) by the addition 
of poly-L-histidine (PLH) and γ-polyglutamic acid (γ-PGA) to enhance its pH-buffering 
effect and suppress cytotoxicity.  The binary and ternary complexes of pDNA with 
PLL or/and PLH showed particle sizes of approximately 52-76 nm with cationic surface 
charge.  The ternary complexes showed much higher gene expression than the binary 
complexes with PLL.  The mixed solution of PLL and PLH showed higher buffering 
capacity than PLL solution.  The high gene expression of ternary complexes was 
reduced by bafilomycin A1.  These results indicated the addition of PLH to PLL 
complexes promoted endosomal escape by enhancing the pH-buffering effect.  The 
binary and ternary complexes showed cytotoxicity and blood agglutination because of 
their cationic surface charge.  We therefore developed quaternary complexes by the 
addition of anionic γ-PGA, which was reported to decrease the toxicity of cationic 
complexes.  In fact, quaternary complexes showed no cytotoxicity and blood 
agglutination.  Also, quaternary complexes showed higher gene expression than 
ternary complexes regardless of their anionic surface charge.  Quaternary complexes 




Thus, we successfully developed the quaternary complexes with high gene expression 
and no toxicity. 
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A wide range of non-viral gene vectors has been developed, such as cationic 
polymers and cationic lipids, for successful gene therapy.1,2  Several advantages of 
cationic polymers in the process of gene transfection have been reported: condensing 
pDNA by electrostatic interaction, binding to the cell surface, take up by the endocytotic 
pathway, and release of pDNA into the cytoplasm.3,4  Among cationic polymers, 
poly-L-lysine (PLL) was one of the first polymers employed for gene transfer, which is 
considered to have an advantage for clinical use because of its biodegradable peptide 
structure.  At physiological pH, the amino groups of PLL were positively charged and 
interact electrostatically with negatively charged DNA, which condensed the DNA in 
the complexes and protected it.5  PLL, however, had a couple of disadvantages for 
clinical use, such as low gene expression and agglutination of blood.6 
The low gene transfection efficiency of PLL was reported to be due to its lack of an 
efficient mechanism for endosomal escape.7  Generally, non-viral gene vectors that can 
escape from endosomes express high gene transfection efficiency.  According to the 
results provided by several groups, using a polymer with high buffering capacity, the 
efficiency of endosomal escape could be increased by increasing the buffering 
capacity.8,9  Gene vectors with buffering capacity lead to osmotic swelling and rupture 
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of endosomes, resulting in the release of vectors into the cytoplasm, a phenomenon 
called the “pH-buffering effect”. 
Histidine has potential as a modification group for gene vectors because of its 
biocompatibility and buffering capacity in the pH range of endosomes.10-13  The 
accumulation of histidine residues inside acidic vesicles can induce the pH-buffering 
effect, which could enhance the endosomal escape rate of the gene vector.  In previous 
studies, there are several reports of histidine vectors such as histidylated polylysine,14 
histidine-rich polymers,15 and histidine-rich peptides.16  Then, we constructed ternary 
complexes which incorporated poly-L-histidine (PLH) into PLL-based gene vectors 
(binary complexes) to achieve more efficient gene transfection. 
On the other hand, the cationic surface of pDNA complexes with cationic polymers 
induced cytotoxicity and blood agglutination caused by their strong interaction with the 
anionic surface of cells and erythrocytes.17  Agglutination of the complexes often led 
to their rapid elimination and adverse effects, such as embolism and inflammatory 
reactions.18-20  Recharging cationic complexes with an anionic compound was reported 
to be a promising method for overcoming these toxicities.21,22  In our previous study, 
we discovered anionic polymers such as γ-polyglutamic acid (γ-PGA),23 chondroitin 
sulfate,24 and hyaluronic acid,24 which decreased the toxicity of cationic complexes 
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while maintaining high transgene efficiency.  Among them, the addition of γ-PGA 
showed the highest gene expression. 
In the present study, we developed modified complexes of pDNA and PLL by the 
addition of PLH and γ-PGA to enhance their pH-buffering effect and suppress 
cytotoxicity.  We investigated the efficacy and safety of these quaternary complexes as 




MATERIALS AND METHODS 
Chemicals 
Bovine serum albumin (BSA), PLL (mean molecular weight: 22,500), and PLH 
(molecular weight: ≥ 5,000) were obtained from Sigma-Aldrich Co. LLC. (St. Louis, 
MO, USA).  The γ-PGA (mean molecular weight: 55,000) was provided by Yakult 
Pharmaceutical Industry Co., Ltd. (Tokyo, Japan).  Fetal bovine serum (FBS) was 
purchased from Biological Industries Ltd. (Kibbutz Beit Haemek, Israel).  RPMI 1640, 
Opti-MEM I, antibiotics (penicillin 100 U/ml and streptomycin 100 µg/ml), and other 
culture reagents were obtained from GIBCO BRL (Grand Island, NY, USA).  
2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium 
salt (WST-1) and 1-methoxy-5-methylphenazinium methylsulfate (1-methoxy PMS) 
were purchased from Dojindo Laboratories (Kumamoto, Japan).  YOYO-1 was 
purchased from Molecular Probes (Leiden, The Netherlands).  All other chemicals 
were of reagent grade. 
 
Construction of pDNA 
pCMV-Luc was constructed by subcloning the Hind III/Xba I firefly luciferase cDNA 
fragment from the pGL3-control vector (Promega, Madison, WI, USA) into the 
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polylinker of the pcDNA3 vector (Invitrogen, Carlsbad, CA, USA).  The pDNA was 
amplified using an EndoFree Plasmid Giga Kit (QIAGEN GmbH, Hilden, Germany).  
The pDNA was dissolved in 5% dextrose solution and stored at -80 °C until analysis.  
The pDNA concentration was measured at 260 nm absorbance and adjusted to 1 mg/ml. 
 
Preparation of binary, ternary, and quaternary complexes 
PLL-PLH mixture was prepared by mixing PLL solution and PLH solution.  To 
prepare binary and ternary complexes, pDNA solution and PLL-PLH mixture were 
mixed by pipetting thoroughly.  The charge ratios of pDNA, PLL, and PLH were 1:8:0 
(PLL8-PLH0 complexes), 1:6:2 (PLL6-PLH2 complexes), 1:4:4 (PLL4-PLH4 
complexes), 1:2:6 (PLL2-PLH6 complexes), or 1:0:8 (PLL0-PLH8 complexes).  To 
prepare quaternary complexes, γ-PGA solution was added to PLL6-PLH2 complexes at 
various charge ratios of 1:6:2:4 (PLL6-PLH2-PGA4 complexes), 1:6:2:6 
(PLL6-PLH2-PGA6 complexes), 1:6:2:8 (PLL6-PLH2-PGA8 complexes), and 1:6:2:10 
(PLL6-PLH2-PGA10 complexes). 
 
Physicochemical properties and gel retardation of complexes 
The particle sizes and ζ-potentials of several complexes were measured using a 
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Zetasizer Nano ZS (Malvern Instruments, Ltd., Malvern, United Kingdom).  The 
number-fractioned mean diameter is shown. 
To determine complex formations, 20 µL aliquots of complex solutions containing 1 
µg pDNA were mixed with 4 µl loading buffer (30% glycerol and 0.2% bromophenol 
blue) and loaded onto a 0.8% agarose gel.  Electrophoresis (i-Mupid J; Cosmo Bio, 
Tokyo, Japan) was carried out at 50 V in running buffer solution (40 mM Tris/HCl, 40 
mM acetic acid, and 1 mM ethylenediaminetetraacetic acid (EDTA)) for 60 min.  The 
retardation of pDNA was visualized with ethidium bromide staining. 
 
Transfection and cellular uptake experiments 
The mouse melanoma cell line, B16-F10 cells, was obtained from the Cell Resource 
Center for Biomedical Research (Tohoku University, Japan).  B16-F10 cells were 
maintained in RPMI 1640 supplemented with 10% FBS and antibiotics (culture 
medium) under a humidified atmosphere of 5% CO2 in air at 37 °C.  B16-F10 cells 
were plated on 24-well plates (Becton-Dickinson and Company, Franklin Lakes, NJ, 
USA) at a density of 1.0 × 104 cells/well and cultivated in 500 µl culture medium.  In 
the transfection experiment, the medium was replaced with 500 µl Opti-MEM I medium 
after 24 h pre-incubation and each complex containing 1 µg pCMV-Luc was added to 
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the cells and incubated for 2 h.  After transfection, the medium was replaced with 
culture medium and cells were cultured for a further 22 h under a humidified 
atmosphere of 5% CO2 in air at 37 °C.  After 22 h incubation, the cells were washed 
with PBS and then lysed in 100 µl lysis buffer (pH 7.8 and 0.1 M Tris/HCl buffer 
containing 0.05% Triton X-100 and 2 mM EDTA).  Ten microliters of lysate samples 
were mixed with 50 µL luciferase assay buffer (PicaGene; Toyo Ink Co., Ltd., Tokyo, 
Japan) and the light produced was immediately measured using a luminometer (Lumat 
LB 9507; EG & G Berthold, Bad Wildbad, German).  The protein content of the lysate 
was determined by the Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA) 
using BSA as a standard.  Absorbance was measured using a microplate reader 
(Sunrise RC-R; Tecan Japan Co., Ltd., Kanagawa, Japan) at 595 nm.  Luciferase 
activity was indicated as relative light units (RLU) per mg protein. 
To visualize the uptake of the complexes, B16-F10 cells were transfected with 
complexes containing of YOYO-1-labeled pCMV-Luc.  After 22 h incubation, the 
relative levels of YOYO-1 in the cells were characterized using fluorescence 





The pHs of PLL solution (3.9 µM) and mixed solution of PLL and PLH were 
adjusted to 3.0 with 2 M HCL, and then the solutions were titrated with 0.01 M NaOH.  
The change of pH was recorded using a pH meter (LAQUA F-72; Horiba Ltd., Kyoto, 
Japan) and plotted for comparison of the buffering capacity between groups.  The 




  Cytotoxicity tests of various complexes on B16-F10 cells were carried out using a 
WST-1 commercially available cell proliferation reagent.  The WST-1 reagent was 
prepared (5 mM WST-1 and 0.2 mM 1-methoxy PMS in PBS) and filtered through a 
0.22 µm filter (Millex-GP; Millipore Co., Bedford, MA, USA) just before the 
experiments.  B16-F10 cells were plated on 96-well plates (Becton-Dickinson and 
Company) at a density of 3.0 × 103 cells/well in the culture medium.  Complexes 
containing 1 µg pDNA in 100 µl Opti-MEM I medium were added to each well and 
incubated for 2 h.  After incubation, the medium was replaced with 100 µl culture 
medium and incubated for another 22 h at 37 °C.  The medium was replaced with 100 
µl culture medium and 10 µl WST-1 reagent was added to each well.  The cells were 
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incubated for an additional 2 h at 37 °C, and absorbance was measured at a wavelength 
of 450 nm with a reference wavelength of 630 nm, using a microplate reader.  The 
results are shown as the percentage to untreated cells. 
 
Inhibition study 
For determination of the endocytotic pathway, after 23 h pre-incubation, B16-F10 cells 
were treated with 0.014 mM chlorpromazine (CPZ) as an inhibitor of clathrin-mediated 
endocytosis, 0.2 mM genistein as an inhibitor of caveolae-mediated endocytosis, or 1 
mM amiloride as an inhibitor of macropinocytosis for 1 h. 
On the other hand, to research their release from endosomes, the cells were treated 
with 100 nM bafiromycin A1 as an ATPase proton pump inhibitor for 1 h. 
After treatment, PLL6-PLH2 complexes or PLL6-PLH2-PGA8 complexes were added 
to the medium containing each inhibitor and incubated for 2 h.  After 2 h transfection, 
the medium was replaced with culture medium, cells were cultured for a further 22 h at 
37 °C, and then luciferase activities were determined. 
 
Agglutination study 
Erythrocytes from mice were washed three times at 4 °C by centrifugation at 5,000 
12 
 
rpm (Kubota 3500; Kubota, Tokyo, Japan) for 5 min and resuspended in PBS.  A 2% 
(v/v) stock suspension was prepared.  Various complexes were added to the 
erythrocytes (complexes: stock suspension = 1:1).  The suspensions were incubated for 
15 min at room temperature.  Ten microliters of these suspensions were placed on a 
glass plate and agglutination was observed by microscopy (400 × magnification). 
 
Animals 
  Animal care and experimental procedures were performed in accordance with the 
Guidelines for Animal Experimentation of Nagasaki University with approval from the 
Institutional Animal Care and Use Committee.  Male ddY mice (5 weeks old) were 
purchased from Japan SLC (Shizuoka, Japan).  After shipping, mice were acclimatized 
to the environment for at least one day before the experiments. 
 
In vivo study 
  Each complex containing 40 µg pCMV-Luc at a volume of 250 µl per mouse was 
injected intravenously into mice to examine the transgene efficacy of PLL-PLH 
complexes and PLL-PLH-PGA complexes.  Six hours after the injection, the mice 
were sacrificed, and the liver, kidney, spleen, heart, and lung were dissected.  The 
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tissues were washed twice with cold saline and homogenized with lysis buffer.  The 
homogenates were centrifuged at 15,000 rpm (Kubota 3500) for 5 min and the 
supernatants were used for luciferase assays.  Luciferase activity is indicated as RLU 
per gram of tissue. 
 
Statistical analysis 
Statistical significance between two groups was identified by Student’s t-test. 
Multiple comparisons among groups were made by Dunnett’s pairwise multiple 




Physicochemical properties and electrophoresis assay of binary and ternary 
complexes 
  The particle sizes and ζ-potentials of the binary and ternary complexes are 
summarized in Table 1.  The complexes showed a particle size of approximately 52-76 
nm and a ζ-potential of approximately 40-48 mV. 
  Complex formations were examined using a gel retardation assay (Fig. 1).  Naked 
pDNA was detected as bands on an agarose gel.  No band was detected in the lanes of 
binary and ternary complexes. 
 
In vitro transfection efficiency and cellular uptake of binary and ternary 
complexes 
B16-F10 cells were transfected with the binary and ternary complexes and luciferase 
activity was evaluated in the cells.  The in vitro transgene efficiencies of the complexes 
are shown in Fig. 2A.  The complexes of pDNA and PLL (PLL8-PLH0 complexes) 
showed 1.34 × 106 RLU/mg protein in transgene efficiency.  On the other hand, the 
gene expressions of ternary complexes were 42.0-fold (PLL6-PLH2 complexes) and 
35.7-fold (PLL4-PLH4 complexes) higher than that of binary complexes (PLL8-PLH0 
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complexes).  PLL2-PLH6 and PLL0-PLH8 complexes showed lower luciferase 
activity than PLL8-PLH0 complexes. 
B16-F10 cells were transfected with PLL8-PLH0, PLL6-PLH2, or PLL0-PLH8 
complexes containing YOYO-1-labeled pCMV-Luc to allow the uptake of the 
complexes to be visualized (Fig. 2B).  As a result, many green dots representing 
YOYO-1 were observed in most of the transfected cells for PLL8-PLH0 and 
PLL6-PLH2 complexes.  On the other hand, PLL0-PLH8 showed low green dots. 
 
pH titration 
  With the addition of 0.01 M NaOH, the pHs of PLL solution and mixed solution of 
PLL and PLH gradually increased.  The mixed solution of PLL and PLH had higher 
buffering capacity between pH 5 and 7 than PLL solution (Fig. 2C). 
 
Physicochemical properties and electrophoresis assay of quaternary complexes 
In the preliminary experiment, the ternary complexes of pDNA (PLL-PLH 
complexes) showed cytotoxicity and agglutination.  Therefore, we prepared quaternary 
complexes of pDNA (PLL-PLH-PGA complexes) by the addition of γ-PGA to 
PLL6-PLH2 complexes.  The particle size and ζ-potential of these PLL-PLH-PGA 
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complexes are shown in Table 2.  While PLL6-PLH2-PGA4 complexes showed 
agglutination, the complexes with charge ratios of 8 or 10 for γ-PGA to pDNA showed a 
particle size of around 100 nm.  The addition of γ-PGA decreased the ζ-potential of 
complexes in a concentration-dependent manner.  PLL-PLH-PGA complexes with 
charge ratios of 8 or 10 for γ-PGA to pDNA had an anionic surface charge.  Gel 
retardation assays were employed to examine the formation of the complexes (Fig. 3).  
Naked pDNA was detected as bands on an agarose gel.  On the other hand, 
PLL-PLH-PGA complexes showed no band of pDNA that was released. 
 
In vitro transfection efficiency of quaternary complexes 
The quaternary complexes containing pCMV-Luc were incubated with B16-F10 cells 
and the luciferase activity in the cells was determined.  The in vitro transgene 
efficiencies of the complexes at various charge ratios are shown in Fig. 4A.  The 
transgene efficiencies of PLL6-PLH2 complexes showed 5.5 × 107 RLU/mg protein.  
The luciferase activity of PLL-PLH-PGA complexes was higher than that of 
PLL6-PLH2 complexes. 
 




  For assessment of the endocytotic pathway, we examined the effects of endocytotic 
inhibitors on the transgene efficiencies of PLL6-PLH2-PGA8 complexes (Fig. 4B).   
The transfection efficiency of PLL6-PLH2-PGA8 complexes in the presence of CPZ, 
genistein, and amilirode decreased to 79.7%, 56.0%, and 40.6% of the original 
efficiency, respectively.   
The influence of 100 nM bafiromycin A1 on transfection efficiency of PLL6-PLH2 
complexes (Fig. 2D) or PLL6-PLH2-PGA8 complexes (Fig. 4C) was determined to 
examine endosomal escape.  Transgene efficiencies were significantly suppressed by 
bafiromycin A1 (P <0.05). 
 
Cytotoxicity and agglutination study of the quaternary complexes 
Each complex was added to B16-F10 cells and cell viability was determined by the 
WST-1 assay to evaluate cytotoxicity (Fig. 5A).  Both PLL8-PLH0 complexes and 
PLL6-PLH2 complexes showed significantly higher cytotoxicity than the control (P 
<0.05).  On the other hand, PLL6-PLH2-PGA8 complexes had no cytotoxicity under 
the same condition. 
Also, each complex was incubated with erythrocytes to evaluate agglutination (Fig. 
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5B).  Severe agglutination was observed in both PLL8-PLH0 complexes and 
PLL6-PLH2 complexes.  However, no agglutination was observed in 
PLL6-PLH2-PGA8 complexes. 
 
In vivo study 
The in vivo transgene efficiencies of PLL8-PLL0 complexes, PLL6-PLH2 complexes, 
and PLL6-PLH2-PGA8 complexes containing pCMV-Luc were examined in ddY male 
mice (Fig. 6).  Luciferase activities in several tissues were determined 6 h after 
intravenous administration of the complexes.  The transgene efficiencies of 
PLL8-PLH0 complexes showed 1.1 × 105 RLU/mg protein in the lung.  On the other 
hand, the gene expressions of PLL6-PLH2-PGA8 complexes were lower in the lung 
(4.7 × 104 RLU/mg protein), and significantly higher in the spleen (3.4 × 105 RLU/mg 





Cationic polymers are one of the most popular non-viral gene vectors due to their 
excellent ability to compact anionic genes, synthetic controllability, better flexibility 
achieved simply by varying the chemical composition, molecular weight, and 
architecture (linear, randomly branched, dendrimer, block, and graft copolymer).25  
Espcially, polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimers show 
high gene expression in vitro and in vivo.26,27  These vectors strongly interact with the 
cell surface, and are well taken up by cells because of their strong cationic surface.  
Moreover, these vectors achieve efficient escape from endosomes to cytoplasm via the 
pH-buffering effect and the gene released from the vector in the cytoplasm expresses 
protein in the nucleus. 
The cationic polymer PLL was reported to show low gene expression because of its 
lack of pH-buffering effect, regardless its high uptake into the cells.6,7,28  Therefore, we 
tried to develop ternary complexes of pDNA with PLL and PLH, which are polymers 
with pH-buffering capacity.  Histidine of PLH, a non-essential amino acid, contains an 
imidazole ring which increases the buffering capacity in endosomes and lysosomes.  
Histidine-containing dipeptides, such as carosine, anserine, and balenine, are also 
known to act as endogenous buffers in skeletal muscle.11,29 
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The binary complexes of pDNA with PLL or PLH showed 76.4 nm or 51.6 nm in 
particle size, and 48.4 mV or 39.9 mV in ζ-potential (Table 1).  The ternary complexes 
of pDNA with PLL and PLH showed similar particle size and ζ-potential.  The binary 
and ternary complexes can include pDNA stably (Fig. 1).  Addition of PLH to pDNA 
and PLL did not greatly affect the manufacturing characteristics of the particles. 
As projected, the gene expressions of ternary complexes which replaced PLL with 
PLH at rates of 25% and 50% (PLL6-PLH2 and PLL4-PLH4 complexes) were 
42.0-fold and 35.7-fold higher than that of binary complexes of pDNA and PLL 
(PLL8-PLL0 complexes), respectively (Fig. 2A).  On the other hand, binary complexes 
with PLH (PLL0-PLH8 complexes) and ternary complexes which replaced PLL with 
PLH at a rate of 75% (PLL2-PLH6 complexes) showed lower luciferase activities.  
PLL0-PLH8 complexes showed very low uptake by cells (Fig. 2B, iii).  Therefore, the 
low gene expression of PLL0-PLH8 complexes was mainly due to the low uptake of 
PLL0-PLH8.    Zhao et al. reported that synthetic histidinylated PLL based gene 
vector showed unstable and low gene expression by introducing many histidine group.30  
Introducing of histidine group to the PLL complexes reduced cationic characteristics of 
the complexes.  The low uptake of PLL0-PLH8 may be caused by slight low cationic 
surface and peculiar structure of PLH. 
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  The mixed solution of PLL and PLH showed higher buffering capacity between pH 5 
and 7 than PLL solution (Fig. 2B).  PEI and histidylated polymers showed similar 
titration profiles through neutral to weakly acidic conditions.31-33  The endosomal 
escape mechanism of pDNA medicated by PEI was supposed to occur via the 
pH-buffering effect.  The imidazole group of histidine had pKa 6.0 34 and thus became 
cationic in slightly acidic conditions. 
  Furthermore, the transfection efficiency of PLL6-PLH2 complexes was markedly 
reduced when cells were incubated in the presence of bafilomycin A1, a specific 
inhibitor of the ATPase responsible for the accumulation of protons inside the endosome 
lumen.35,36  On the other hand, strong cellular uptake of both the PLL8-PLH0 and 
PLL6-PLH2 complexes was observed during experiments involving complexes 
containing pDNA labelled with YOYO-1.  These results indicate that the addition of 
PLH to PLL complexes induced endosomal escape by enhancing the pH-buffering 
effect to increase the gene expression. 
The strong interaction of cationic complexes to anionic cell membrane often cause to 
strong cytotoxicity and blood agglutination.  In fact, cationic complexes such as binary 
complexes with PLL and ternary complexes of PLL6-PLH2 complexes showed strong 
cytotoxicity and blood agglutination (Fig. 5).  One promising approach to overcoming 
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such cytotoxicity is the addition of anionic polymers to cationic complexes.  For 
example, we previously found that γ-PGA decreased the toxicity of cationic 
compounds.23  Therefore, we developed quaternary complexes of pDNA by the 
addition of γ-PGA to PLL6-PLH2 complexes. 
The addition of anionic polymers often caused the release of pDNA containing the 
complexes.  However, the addition of PGA did not release pDNA from quaternary 
complexes (Fig. 3).  Complexes with charge ratios of 8 or 10 for γ-PGA to pDNA 
(PLL6-PLH2-PGA8 and PLL6-PLH2-PGA10 complexes) showed a particle size of 
around 100 nm with anionic surface charge, suggesting stable anionic particles.  The 
anionic surface charge of complexes largely reduced cell surface interaction and blood 
agglutination to decrease cytotoxicity and blood toxicity.  In fact, the change in the 
surface charge from positive to negative markedly decreased cytotoxicity and blood 
agglutination (Fig. 5).  The addition of alginic acid and anionic PEG derivatives to 
cationic complexes was also demonstrated to reduce cytotoxicity and blood 
agglutination by changing the surface charge.37,38 
On the other hand, the anionic surface charge of particles also reduced gene 
expression by decreasing cell surface interactions.  We prepared various anionic 
coating complexes and most could not be taken up well by cells and showed low gene 
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expression.23  Among these anionic polymers, however, we discovered that γ-PGA was 
a rare constituent which was taken up by cells and showed high gene expression.23  In 
fact, all quaternary complexes coated with γ-PGA showed high gene expression 
comparable to ternary complexes (PLL6-PLH2 complexes) (Fig. 4A).  These 
transfection efficiencies were as great as the commercially available transfection reagent, 
lipofectin (1.5 × 108 RLU/mg protein)39, although their transgene efficacies were lower 
than those of the binary complexes of pDNA with PAMAM (1.4 × 109 RLU/mg protein) 
or PEI (2.2 × 1010 RLU/mg protein).  However, PAMAM and PEI are not 
biodegradable and exhibit strong toxicity 40,41, therefore they are not available yet for 
clinical use. The present quaternary complexes are biodegradable and are constructed by 
self-assembly.  They showed no cytotoxicity and blood toxicity.  The complexes may 
be easily manufactured with sterilization and expected for clinical use. 
In the previous report, we confirmed that γ-PGA-coated complex was taken up by an 
energy-dependent process and γ-PGA-specific receptor-mediated pathway using 
B16F10 cells.23  Then, to clarify the mechanisms responsible for the uptake of the 
complexes, we performed an inhibition study with various endocytotic inhibitors, such 
as chlorpromazine (CPZ) for clathrin-mediated endocytosis, genistein for 
caveolae-mediated endocytosis, and amiloride for macropinocytosis.4  The transgene 
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efficiency of PLL6-PLH2-PGA8 complexes was markedly decreased in the presence of 
amiloride, suggesting that macropinocytosis must be the primary route of transfection 
for PLL-PLH-PGA complexes (Fig. 4B).  Furthermore, the transfection efficiency of 
PLL6-PLH2-PGA8 complexes was markedly inhibited by bafiromycin A1.  This result 
indicated that quaternary complexes have the pH-buffering efficiency of PLH. 
For the clinical gene therapy, not only high transfection efficiency but also 
biocompatibility for frequent dosing is indispensable.  PLL6-PLH2-PGA8 complexes 
showed high gene transfection efficiency without cytotoxicity and agglutination, 
indicating their utility as a clinical gene delivery system.  We therefore determined the 
in vivo transgene efficiencies of PLL6-PLH2-PGA8 complexes.  PLL6-PLH2-PGA8 
complexes showed high gene expression in the spleen (3.4 × 105 RLU/mg protein) after 
intravenous injection (Fig. 6).  Sutherland et al. reported that poly-γ-D-glutamic acid 
(γDPGA), which is a capsular component of Bacillus anthracis, was mainly 
accumulated in the spleen and liver after intravenous injection into mice.42,43  In 
particular, γDPGA was located in red pulp in the spleen and Kupffer cells and sinusoidal 
endothelial cells in the liver. PLL6-PLH2-PGA8 complexes may be taken up by splenic 
macrophage through a similar mechanism of γDPGA.  Various γ-PGA-coated 
complexes were reported to be accumulated in the limbic system of the spleen and 
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showed gene expression after their intravenous injection into mice.44  It was reported 
that the gene vector which showed high gene expression in the spleen was an effective 
DNA vaccine for malaria.45 
Thus, we successfully modified binary complexes of pDNA with PLL by the addition 
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Figure 1.  
Electrophoretic migration of pDNA in binary and ternary complexes through agarose 
gel. PLL-PLH complexes were loaded onto an agarose gel, and electrophoresis was 
carried out.  The retardation of pDNA was visualized using ethidium bromide. 
 
Figure 2.  
(A) In vitro transfection efficiencies of PLL-PLH complexes.  B16-F10 cells were 
transfected with various complexes containing pCMV-Luc.  Twenty-two hours after 
transfection, cells were lysed and luciferase activities were determined.  Each value is 
the mean ± S.E. (n = 3).  *P <0.05 vs. PLL8-PLH0 complex. 
(B) Fluorescence microscopy images of transfected B16-F10 cells. B16-F10 cells were 
transfected with YOYO-1 labeled pCMV-Luc-containing complexes. Twenty-two hours 
after the cells had been transfected, the uptake of PLL8-PLH0 (i), PLL6–PLH2 (ii), and 
PLL0-PLH8 complexes (iii) was assessed (200 × magnification). 
(C) Buffering capacity of PLL and PLL-PLH solution.  NaOH 0.01 M was used to 
titrate the PLL solution or mixed solution of PLL and PLH.  Molar ratio of PLL to 




(D) PLL6-PLL2 complexes were transfected in medium with bafiromycin A1.  
Twenty-two hours after transfection, cells were lysed and luciferase activities were 
determined.  Each value is the mean ± S.E. (n = 3).  *P <0.05 vs. control. 
 
Figure 3. 
Electrophoretic migration of pDNA in quaternary complexes through agarose gel. 
PLL-PLH-PGA complexes were loaded onto an agarose gel, and electrophoresis was 
carried out.  The retardation of pDNA was visualized using ethidium bromide. 
 
Figure 4. 
(A) In vitro transfection efficiencies of PLL-PLH-PGA complexes.  B16-F10 cells 
were transfected with various complexes containing pCMV-Luc.  Twenty-two hours 
after transfection, cells were lysed and luciferase activities were determined.  Each 
value is the mean ± S.E. (n = 3).  *P <0.05 vs. PLL6-PLH2 complex. 
(B) Influence of endocytotic inhibitors on the transfection efficiency of 
PLL6-PLH2-PGA8 complexes.  PLL6-PLL2-PGA8 complexes were transfected in 
medium with various endocytotic inhibitors.  Twenty-two hours after transfection, cells 
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were lysed and luciferase activities were determined.  Each value is the mean ± S.E. (n 
= 3). 
(C) Influence of endocytotic inhibitors bafiromycin A1 on the transfection efficiency of 
PLL6-PLH2-PGA8 complexes.  PLL6-PLL2-PGA8 complexes were transfected in 
medium with bafiromycin A1.  Twenty-two hours after transfection, cells were lysed 
and luciferase activities were determined.  Each value is the mean ± S.E. (n = 3).  *P 
<0.05 vs. control. 
 
Figure 5. 
(A) Cytotoxicity of the complexes on B16-F10 cells.  The viability of cells treated with 
each complex was measured by the WST-1 assay.  Cell viability was measured 22 h 
after cells had been incubated with the complexes for 2 h.  Data are the percentage to 
untreated cells.  Each value is the mean ± S.E. (n = 8).  *P <0.05 vs. control. 
(B) Agglutination of complexes with erythrocytes.  Each complex was added to 
erythrocytes, and agglutination was observed by microscopy (400 × magnification).  






In vivo transgene efficiencies of the complexes in mice.  The complexes were injected 
intravenously into mice (40 µg DNA per mouse).  Six hours after the injection, mice 
were sacrificed and each organ was dissected to quantify luciferase activity.  
PLL8-PLL0 complex (  ), PLL6-PLH2 complex (  ) and PLL6-PLH2-PGA8 complex 














Particle size and ζ-potential of binary and ternary complexes. 
2 
Table 2 
Particle size and ζ-potential of quaternary complexes. 
